No association of the hypercoagulable state with sickle cell disease related pulmonary hypertension

Haematologica

Volumn 93, Issue 5, 2008, Pages

  Van Beers, E J ^a   Spronk, H M H ^b   Ten Cate, H ^b   Duits, A J ^c   Brandjes, D P M ^d   Van Esser, J W J ^e   Biemond, B J ^a   Schnog, J B ^c,d,e  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Red Cross Blood Bank Foundation   (Netherlands Antilles)

^d SLOTERVAART HOSPITAL   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT THROMBOPLASTIN; THROMBIN;

DISEASE ASSOCIATION; HEMOLYSIS; HUMAN; HYPERCOAGULABILITY; LETTER; PULMONARY HYPERTENSION; SICKLE CELL ANEMIA; THALASSEMIA; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; ANEMIA, SICKLE CELL; ECHOCARDIOGRAPHY; FEMALE; HEMOLYSIS; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PROTHROMBIN; PULMONARY ARTERY; RADIONUCLIDE IMAGING; RISK FACTORS; THROMBOPHILIA; THROMBOSIS;

EID: 43449096658     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12632     Document Type: Letter

References (10)

1. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004;350:886-95.
2. Johnson SR, Granton JT, Mehta S. Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Chest 2006;130:545-52.
3. Ataga KI, Cappellini MD, Rachmilewitz EA. Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability. Br J Haematol 2007;139:3-13.
4. Adedeji MO, Cespedes J, Allen K, Subramony C, Hughson MD. Pulmonary thrombotic arteriopathy in patients with sickle cell disease. Archiv Pathol Lab Med 2001;125:1436-41.
5. Anthi A, Machado RF, Jison ML, Taveira-Dasilva AM, Rubin LJ, Hunter L, et al. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Resp Crit Care Med 2007;175:1272-9.
6. van Beers EJ, van Eck-Smit BL, Mac Gillavry MR, van Tuijn CF, van Esser JW, Brandjes DP, et al. Large and medium sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle cell disease associated pulmonary hypertension. Chest 2008;133:646-52.
7. Dielis AW, Castoldi E, Spronk HM, van Oerle R, Hamulyak K, Ten Cate H, et al. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 2008;6:125-31.
8. Ataga KI, Moore CG, Hillery CA, Jones S, Whinna HC, Strayhorn D, et al. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension. Haematologica 2008;93:20-6.
9. Singer ST, Kuypers FA, Styles L, Vichinsky EP, Foote D, Rosenfeld H. Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol 2006;81:670-5.
10. Schnog JB, Mac Gillavry MR, van Zanten AP, Meijers JC, Rojer RA, Duits AJ, et al. Protein C and S and inflammation in sickle cell disease. Am J Hematol 2004;76:26-32.